Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Berlin

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Nature Genetics|March 25, 2025
The landscape of N<sup>6</sup>-methyladenosine in localized primary prostate cancerXin Xu, Helen Zhu, Rupert Hugh-White, et al.
The Lancet. Oncology|December 3, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort studyEmilie Lalonde, Adrian S Ishkanian, Jenna Sykes, et al.
JAMA Oncology|October 22, 2020
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the ProstateRobert T Dess, Krithika Suresh, Michael J Zelefsky, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium AnalysisSagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
European Urology|May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate CancerRebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
Nature Genetics|May 26, 2015
Spatial genomic heterogeneity within localized, multifocal prostate cancerPaul C Boutros, Michael Fraser, Nicholas J Harding, et al.
JAMA Oncology|January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 CohortsAmar U Kishan, Alison Steigler, James W Denham, et al.
JAMA Network Open|July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic FeaturesAmar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
Nature|January 10, 2017
Genomic hallmarks of localized, non-indolent prostate cancerMichael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Nature Genetics|March 25, 2025
The landscape of N<sup>6</sup>-methyladenosine in localized primary prostate cancerXin Xu, Helen Zhu, Rupert Hugh-White, et al.
The Lancet. Oncology|December 3, 2014
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort studyEmilie Lalonde, Adrian S Ishkanian, Jenna Sykes, et al.
JAMA Oncology|October 22, 2020
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the ProstateRobert T Dess, Krithika Suresh, Michael J Zelefsky, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2022
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium AnalysisSagar A Patel, Ting Martin Ma, Jessica K Wong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 11, 2025
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensusConstantinos Zamboglou, William De Doncker, Andreas Thomas Christoforou, et al.
European Urology|May 14, 2021
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate CancerRebecca G Philipson, Tahmineh Romero, Jessica K Wong, et al.
Nature Genetics|May 26, 2015
Spatial genomic heterogeneity within localized, multifocal prostate cancerPaul C Boutros, Michael Fraser, Nicholas J Harding, et al.
JAMA Oncology|January 20, 2022
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 CohortsAmar U Kishan, Alison Steigler, James W Denham, et al.
JAMA Network Open|July 1, 2021
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic FeaturesAmar U Kishan, R Jeffrey Karnes, Tahmineh Romero, et al.
Nature|January 10, 2017
Genomic hallmarks of localized, non-indolent prostate cancerMichael Fraser, Veronica Y Sabelnykova, Takafumi N Yamaguchi, et al.
Pageof 23